Cystic fibrosis and Pseudomonas aeruginosa: Current and future strategies;Mucoviscidose et Pseudomonas aeruginosa: Stratégies actuelles et à venir

Journal de Pharmacie de Belgique

Volumn 62, Issue 1, 2007, Pages 25-28

  Leonard, A ^a   Leal, T ^a   Lebecque, Patrick ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM; CIPROFLOXACIN; NEOMYCIN; TOBRAMYCIN;

DISEASE EXACERBATION; HUMAN; LUNG FIBROSIS; PATHOGENESIS; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; REVIEW;

CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS INFECTIONS;

EID: 34147190996     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Cystic Fibrosis Foundation Patient Registry. Annual data report. Bethesda (MD), USA : Cystic Fibrosis Foundation ; 2002.
2. Cystic Fibrosis Foundation, Patient Registry 1996. Annual Data Report, Bethesda, Maryland, August 1997.
3. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001; 32 : 277-287.
4. Baumann U, Stocklossa C, Greiner W, von der Schulenburg JM, von der Hardt H. Cost of the care and clinical condition in paediatric cystic fibrosis patients. J Cyst Fibros 2003; 2 : 84-290.
5. Koch C. Early infection and progression of cystic fibrosis lung disease. Pediatr Pulmonol 2002 ; 34 : 232-236.
6. Lee T, Brownlee K, Denton M, Littlewood J, Conway S. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional paediatric cystic fibrosis centre. Pediatr Pulmonol. 2004 ; 37 : 104-110.
7. Frederiksen B, Koch C, Hoiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999 ;28:159-166.
8. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, Mc Coy K, Mc Namara S, Ramsey B, Wagener J. Diagnosis accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999 ; 28 : 321-328.
9. Perdersen SS, Espersen F, Hoiby N. Diagnosis of chronic Pseudomonas Aeruginosa infection in cystic fibrosis by enzyme-linked inmunosorbent assay. J Clin Microbiol 1987 ; 25 : 1830-1836.
10. Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, Touw DJ. Antibiotic therapy against Pseudomonas aeurginosa in cystic fibrosis : a European consensus. Eur Respir J 2000 ; 15 : 749-767.
11. Lee T, Brownlee K, Conway S, Denton M, Littlewood J. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003 ; 2 : 29-34.
12. Littlewood JM, Miller MG, Ghoneim AT, Ramsden CH. Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis. Lancet 1984; i :865.
13. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338 : 725-726.
14. Frederiksen B, Koch C , Hoiby N. Antibiotic treatment of initial colonisation with Pseudomonas aeruginosa post-pones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997 ; 23 : 330-335.
15. Wiesemann H, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Doring G, von der Hardt H. Placebo-controlled, double -blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis. Pediatr Pulmonol. 1998 ; 25 : 88-92.
16. Ratjen F, Döring G, Nikolaizik W. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet. 2001; 358 : 983-984.
17. Tacetti G, Repetto T, Procopio E, Farina S, Campana S. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients. Lancet 2002 ; 359 :625 - 625 (letter).
18. Heinzl B, Eber E, Oberwaldner B, Haas G, Zach MS. Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. A pilot study. Pediatr Pulmonol 2002 ; 33 : 32-37.
19. Lebecque P, Leal T, Zylberberg K, Reychler G, Bossuyt X, Godding V. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros 2006 ; 5 : 237-244.
20. Maselli JH, Sontag MK, Norris JM, Mac Kenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with CF identified by newborn screening. Pediatr Pulmonol 2003; 35 : 257-262.
21. Stutman HR, Lieberman JM, Nussbaum E, Marks MI. Antibiotic prophylaxis in infants and young children with cystic fibrosis : a randomised controlled trial. L pediatr 2002 ; 140 : 299-305.
22. Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonisation in cystic fibrosis patients. Pediatr Infect Dis J. 1990 ; 9 : 494-498.
23. Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992 ; 47 : 109-111,
24. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatric Pulmonol. 1998 ; 26 : 81-88.
25. de Groot R and Smith AL. Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. Clin Pharmacokinet 1987, 13 : 228-253.
26. Clement A, Tamalet A, Leroux E, Ravilly S, Fauroux B and Jais JP. Long term effects of azithromycin in patients with cystic fibrosis : A double blind, placebo controlled trial. Thorax 2006, 61 : 892-902.
27. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol 1997 ; 24 : 42-47.
28. Thornton J, Elliott R, Tully MP, Dodd M, Webb AK. Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004 ; 59 : 242-246.